AAIC 2025 Abstract
Targeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer's Disease in African Americans
By Vanessa M. Colon Badillo, Joseph S. Reddy, Jiangli Jin, Show 14 more authorsMinerva M. Carrasquillo
Study in peopleBiomarkers
Abstract
Background: African Americans (AA) are twice as likely to develop dementia than non‐Hispanic Whites but remain underrepresented in Alzheimer's Disease (AD) research. Recent studies have identified AA specific risk factors for AD. Therefore, targeted biomarkers and/or therapies may be needed to effectively treat AD in AA.
